Trial Profile
Randomised Comparative Study of the Efficacy and Safety of Rosuvastatin and Pravastatin in Dyslipidemic Patients Treated With Antiretroviral Agents. Anrs 126.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2012
Price :
$35
*
At a glance
- Drugs Pravastatin (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 17 Mar 2011 Results of a sub-study that investigated the effects of treatment on hsCRP levels published in AIDS.
- 02 Jan 2010 Results published in AIDS.
- 07 Feb 2008 Status changed from in progress to completed.